LOX and glioblastoma: To confirm the expression pattern of LOX, we analyzed the single-cell RNA sequencing (scRNA-seq) data from tumors of patients with GBM (31) with results showing that LOX was highly expressed in mesenchymal GBM cells, which account for 29.23% of total malignant cells (Figure 1, A–C).